Core Viewpoint - The company, Baize Medical (02609.HK), has been selected to be included in various Hang Seng Index series, effective from September 8, 2025, reflecting increased recognition of its operational performance, investment value, and growth potential by investors [1] Group 1: Index Inclusion - The company will be included in the following Hang Seng Index series: 1. Hang Seng Composite Index; 2. Hang Seng Composite Industry Index - Healthcare; 3. Hang Seng Composite Small Cap Index; 4. Hang Seng Composite Mid Cap Index; 5. Hang Seng Healthcare Index; 6. Hang Seng Hong Kong Stock Connect Healthcare Equipment and Services (Investable) Index; 7. Hang Seng Hong Kong Stock Connect Healthcare Equipment and Services Index [1] Group 2: Market Impact - The board believes that inclusion in the Hang Seng Composite Index and the aforementioned indices will enhance the company's visibility in the capital market, improve the liquidity of its shares, and further increase its investment value [1]
佰泽医疗(02609.HK)获纳入恒生指数系列成份股